Ultragenyx
Price & Volume
Stats
See more52W Range | $25.81-$50 |
Market Cap | $3.3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $630.5M |
Revenue Growth (YoY) | 14.7% |
Gross Profit (12 Mos) | -$163.8M |
Diluted EPS | -$5.93 |
News
See moreYahoo Finance • 22 hours ago
Barclays Remains Cautious on Ultragenyx (RARE), Cites Setrusumab Study Analysis Despite 70% Positive Result Outlook
Yahoo Finance • 5 days ago
Ultragenyx to Participate in Investor Conferences in December
Yahoo Finance • 8 days ago
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 24 days ago
Ultragenyx outlines 14%–20% 2025 revenue growth, advances late-stage pipeline with $400M OMERS financing
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,294 |
